Disc Medicine Stock Total Asset

IRON Stock   58.25  1.70  2.84%   
Disc Medicine fundamentals help investors to digest information that contributes to Disc Medicine's financial success or failures. It also enables traders to predict the movement of Disc Stock. The fundamental analysis module provides a way to measure Disc Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Disc Medicine stock.
Last ReportedProjected for Next Year
Total Assets423.2 M215.2 M
As of the 19th of January 2025, Total Assets is likely to drop to about 215.2 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Disc Medicine Company Total Asset Analysis

Disc Medicine's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Total Asset

 = 

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current Disc Medicine Total Asset

    
  368 M  
Most of Disc Medicine's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Disc Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Disc Total Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Disc Medicine is extremely important. It helps to project a fair market value of Disc Stock properly, considering its historical fundamentals such as Total Asset. Since Disc Medicine's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Disc Medicine's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Disc Medicine's interrelated accounts and indicators.
0.84-0.65-0.04-0.88-0.870.84-0.69-0.040.99-0.710.87-0.690.85-0.68-0.690.78
0.84-0.48-0.36-0.81-0.790.73-0.54-0.330.81-0.470.87-0.530.83-0.53-0.530.53
-0.65-0.48-0.580.890.91-0.811.0-0.59-0.70.98-0.841.0-0.861.01.0-0.95
-0.04-0.36-0.58-0.21-0.260.07-0.541.00.07-0.580.14-0.550.21-0.55-0.550.52
-0.88-0.810.89-0.211.0-0.890.92-0.23-0.90.89-0.980.92-0.980.910.92-0.9
-0.87-0.790.91-0.261.0-0.890.93-0.27-0.890.91-0.980.93-0.980.930.93-0.91
0.840.73-0.810.07-0.89-0.89-0.830.060.82-0.840.85-0.830.84-0.83-0.830.85
-0.69-0.541.0-0.540.920.93-0.83-0.56-0.740.99-0.881.0-0.91.01.0-0.97
-0.04-0.33-0.591.0-0.23-0.270.06-0.560.08-0.580.17-0.560.24-0.56-0.560.53
0.990.81-0.70.07-0.9-0.890.82-0.740.08-0.760.89-0.740.88-0.73-0.740.82
-0.71-0.470.98-0.580.890.91-0.840.99-0.58-0.76-0.830.99-0.850.990.99-0.99
0.870.87-0.840.14-0.98-0.980.85-0.880.170.89-0.83-0.881.0-0.87-0.880.86
-0.69-0.531.0-0.550.920.93-0.831.0-0.56-0.740.99-0.88-0.91.01.0-0.97
0.850.83-0.860.21-0.98-0.980.84-0.90.240.88-0.851.0-0.9-0.89-0.90.88
-0.68-0.531.0-0.550.910.93-0.831.0-0.56-0.730.99-0.871.0-0.891.0-0.97
-0.69-0.531.0-0.550.920.93-0.831.0-0.56-0.740.99-0.881.0-0.91.0-0.97
0.780.53-0.950.52-0.9-0.910.85-0.970.530.82-0.990.86-0.970.88-0.97-0.97
Click cells to compare fundamentals

Disc Total Asset Historical Pattern

Today, most investors in Disc Medicine Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Disc Medicine's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Disc Medicine total asset as a starting point in their analysis.
   Disc Medicine Total Asset   
       Timeline  
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition

Disc Total Assets

Total Assets

215.24 Million

At this time, Disc Medicine's Total Assets are very stable compared to the past year.
Based on the latest financial disclosure, Disc Medicine has a Total Asset of 368 M. This is 95.11% lower than that of the Biotechnology sector and 81.38% lower than that of the Health Care industry. The total asset for all United States stocks is 98.75% higher than that of the company.

Disc Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Disc Medicine's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Disc Medicine could also be used in its relative valuation, which is a method of valuing Disc Medicine by comparing valuation metrics of similar companies.
Disc Medicine is currently under evaluation in total asset category among its peers.

Disc Medicine ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Disc Medicine's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Disc Medicine's managers, analysts, and investors.
Environmental
Governance
Social

Disc Fundamentals

About Disc Medicine Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Disc Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Disc Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Disc Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Disc Medicine

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Disc Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Disc Medicine will appreciate offsetting losses from the drop in the long position's value.

Moving against Disc Stock

  0.82EQ EquilliumPairCorr
  0.79VALN Valneva SE ADRPairCorr
  0.7ME 23Andme HoldingPairCorr
  0.68DRRX DurectPairCorr
  0.67VINC Vincerx PharmaPairCorr
The ability to find closely correlated positions to Disc Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Disc Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Disc Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Disc Medicine to buy it.
The correlation of Disc Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Disc Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Disc Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Disc Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Disc Medicine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Disc Medicine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Disc Medicine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Disc Medicine Stock:
Check out Disc Medicine Piotroski F Score and Disc Medicine Altman Z Score analysis.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Disc Medicine. If investors know Disc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Disc Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.95)
Return On Assets
(0.18)
Return On Equity
(0.25)
The market value of Disc Medicine is measured differently than its book value, which is the value of Disc that is recorded on the company's balance sheet. Investors also form their own opinion of Disc Medicine's value that differs from its market value or its book value, called intrinsic value, which is Disc Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Disc Medicine's market value can be influenced by many factors that don't directly affect Disc Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Disc Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.